...
首页> 外文期刊>Clinical, Cosmetic and Investigational Dermatology >Topical effects of N-acetyl-L-hydroxyproline on ceramide synthesis and alleviation of pruritus
【24h】

Topical effects of N-acetyl-L-hydroxyproline on ceramide synthesis and alleviation of pruritus

机译:N-乙酰基-L-羟基脯氨酸对神经酰胺合成和减轻瘙痒症的局部作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: N-acetyl-l-hydroxyproline (AHYP) is an acetylated form of l-hydroxyproline that is used to treat skin ulcers and porphyria cutanea tarda. Its other biological and physiological effects on the skin have not been elucidated. We investigated the effects of AHYP on the skin-barrier function, focusing on ceramide synthesis and the effects of topical AHYP on atopic dermatitis.Materials and methods: AHYP was applied to a three-dimensional cultured skin model. Ceramides were quantified by high-performance thin-layer chromatography. Serine palmitoyltransferase (SPT) is the rate-limiting enzyme in de novo ceramide synthesis, and the mRNA of its long-chain base subunit 1 (SPTLC1) was evaluated by quantitative reverse-transcription polymerase chain reaction. A clinical trial in the form of an intraindividual, comparative, double-blind, randomized, vehicle-controlled test involving 15 female subjects suffering from slight atopic dermatitis was performed. Subjects applied 1% (w/w) AHYP cream to one forearm and a control cream to the other forearm twice daily for 4 weeks. Skin condition was evaluated by measuring transepidermal water loss (TEWL). Dermatological observations were made by a dermatologist, and subjects evaluated their own pruritus intensity before beginning treatment and 4 weeks after the start of treatment.Results: SPTLC1 expression and ceramide synthesis were significantly increased in an AHYP-treated skin model (P < 0.05). In the clinical trial, no adverse effects were observed in any subjects. TEWL was increased in the control-treated region of the forearm (P < 0.05) after 4 weeks' application, whereas there was no change in the AHYP-treated region of the forearm. Pruritus intensity declined in the AHYP-treated forearms between 0 and 4 weeks (P < 0.05), but there was no change in the control-treated forearms.Conclusion: AHYP increased ceramide synthesis by upregulating SPTLC1 in a three-dimensional cultured skin model, and it prevented TEWL increase and alleviated pruritus in human subjects with slight atopic dermatitis.
机译:目的:N-乙酰基-1-羟基脯氨酸(AHYP)是L-羟基脯氨酸的乙酰化形式,用于治疗皮肤溃疡和皮肤卟啉病。还没有阐明其对皮肤的其他生物学和生理作用。我们研究了AHYP对皮肤屏障功能的影响,重点是神经酰胺合成以及局部AHYP对特应性皮炎的影响。材料与方法:将AHYP应用于三维培养的皮肤模型。通过高效薄层色谱对神经酰胺进行定量。丝氨酸棕榈酰转移酶(SPT)是从头神经酰胺合成中的限速酶,并通过定量逆转录聚合酶链反应评估了其长链碱基亚基1(SPTLC1)的mRNA。进行了一项临床试验,该试验以单项,比较,双盲,随机,对照试验的形式进行,涉及15名患有轻度特应性皮炎的女性受试者。受试者每天两次将1%(w / w)AHYP乳膏涂在一个前臂上,将对照乳膏涂在另一个前臂上,每天两次,持续4周。通过测量经皮表皮失水量(TEWL)评估皮肤状况。由皮肤科医生进行皮肤病学观察,受试者在开始治疗前和治疗开始后4周评估了自己的瘙痒强度。结果:在AHYP治疗的皮肤模​​型中SPTLC1表达和神经酰胺合成显着增加(P <0.05)。在临床试验中,在任何受试者中均未观察到不良反应。施用4周后,前臂的对照治疗区TEWL升高(P <0.05),而AHYP治疗的前臂区没有变化。在0至4周之间,AHYP治疗前臂的瘙痒强度下降(P <0.05),但对照治疗前臂则没有变化。结论:在三维培养的皮肤模型中,AHYP通过上调SPTLC1来增加神经酰胺的合成,并预防了患有轻微特应性皮炎的人类受试者的TEWL升高并减轻了瘙痒症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号